Contact this trialFirst, we need to learn more about you.
MDM2 Inhibitor
APG-115 + Azacitidine for Acute Myeloid Leukemia
Recruiting1 awardPhase 1 & 2
Gilbert, Arizona
This trial is testing a new drug, APG-115, to see if it is safe and effective in treating patients with relapsed or refractory leukemia.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.